How frequently does hepatocellular carcinoma develop in at-risk patients with a negative liver MRI examination with intravenous Gadobenate dimeglumine?
Islam H. Zaki, Erin Shropshire, Shuaiqi Zhang, Xiao Dong, Benjamin Wildman‐Tobriner, Daniele Marin, Rajan T. Gupta, Alaattin Erkanli, R. C. Nelson, Mustafa R. Bashir
Topics & Concepts
MedicineHepatocellular carcinomaNodule (geology)Cumulative incidenceCirrhosisHepatologyIncidence (geometry)RadiologyMagnetic resonance imagingPopulationInternal medicineCohortEnvironmental healthPhysicsPaleontologyOpticsBiologyHepatocellular Carcinoma Treatment and PrognosisLiver Disease Diagnosis and TreatmentLiver Disease and Transplantation